PIH5 COSTS AND OUTCOMES ASSOCIATED WITH USE OF RECOMBINANT FOLLICLE STIMULATING HORMONE (RFSH) DURING IN VITRO FERTILISATION (IVF) TREATMENT IN A UNITED KINGDOM CENTRE
Abstract
Authors
WL Ledger CJ Wiebinga AJ Holman DE Irwin AC Lloyd